Stapleton & Colden Competitors

Invesco Ltd. is one of the world’s leading asset managers, with 8,300 employees helping retail and institutional investors in more than 120 countries rethink their challenges and find new possibilities for success. Our collaborative mindset, breadth of solutions and global scale mean there are few problems we can’t help our clients address and few opportunities we can’t help them explore. Our capabilities span nearly every asset class, investment strategy and vehicle, which means we’re able to offer, create or customize solutions to address a broad range of client needs, as the world continues to evolve at pace. Our investing talent and experience, advanced portfolio and risk analytics, market intelligence, research and insights help our clients make highly informed decisions. Our commitment to adding value goes beyond our products, for example helping advisory clients rethink how to elevate their own client interactions, strengthen their investment process and innovate their practices. For disclosure, visit https://www.invesco.com/corporate/en/socialmedia.html.

Point72 is a leading global alternative investment firm led by Steven A. Cohen. Building on more than 30 years of investing experience, Point72 seeks to deliver superior returns for its investors through fundamental and systematic investing strategies across asset classes and geographies. We aim to attract and retain the industry’s brightest talent by cultivating an investor-led culture and committing to our people’s long-term growth.

American Century Investments is a leading global asset manager focused on delivering results that can help our clients reach their most important financial goals. Investing with us also means investing in a healthier world, as 40% of our dividends go to life-changing medical research every year. Helping deliver investment results for clients allows the firm to help fund the Stowers Institute for Medical Research, its controlling owner. To date, the Stowers Institute has received over $2 billion* to fund its mission of making a significant impact on humanity by defeating diseases that touch all of us, like cancer and Alzheimer’s. *As of 12/31/2025.